Janus Henderson Group PLC Neurocrine Biosciences Inc Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 971,203 shares of NBIX stock, worth $115 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
971,203
Previous 1,378,513
29.55%
Holding current value
$115 Million
Previous $190 Million
29.67%
% of portfolio
0.07%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.68 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.19 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$545 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$292 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$280 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...